Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults
- PMID: 19793855
- DOI: 10.3945/ajcn.2009.28380
Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults
Abstract
Background: The ability of modified alternate-day fasting (ADF; ie, consuming 25% of energy needs on the fast day and ad libitum food intake on the following day) to facilitate weight loss and lower vascular disease risk in obese individuals remains unknown.
Objective: This study examined the effects of ADF that is administered under controlled compared with self-implemented conditions on body weight and coronary artery disease (CAD) risk indicators in obese adults.
Design: Sixteen obese subjects (12 women, 4 men) completed a 10-wk trial, which consisted of 3 phases: 1) a 2-wk control phase, 2) a 4-wk weight loss/ADF controlled food intake phase, and 3) a 4-wk weight loss/ADF self-selected food intake phase.
Results: Dietary adherence remained high throughout the controlled food intake phase (days adherent: 86%) and the self-selected food intake phase (days adherent: 89%). The rate of weight loss remained constant during controlled food intake (0.67 +/- 0.1 kg/wk) and self-selected food intake phases (0.68 +/- 0.1 kg/wk). Body weight decreased (P < 0.001) by 5.6 +/- 1.0 kg (5.8 +/- 1.1%) after 8 wk of diet. Percentage body fat decreased (P < 0.01) from 45 +/- 2% to 42 +/- 2%. Total cholesterol, LDL cholesterol, and triacylglycerol concentrations decreased (P < 0.01) by 21 +/- 4%, 25 +/- 10%, and 32 +/- 6%, respectively, after 8 wk of ADF, whereas HDL cholesterol remained unchanged. Systolic blood pressure decreased (P < 0.05) from 124 +/- 5 to 116 +/- 3 mm Hg.
Conclusion: These findings suggest that ADF is a viable diet option to help obese individuals lose weight and decrease CAD risk. This trial was registered at clinicaltrials.gov as UIC-004-2009.
Similar articles
-
Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial.Nutr J. 2013 Nov 12;12(1):146. doi: 10.1186/1475-2891-12-146. Nutr J. 2013. PMID: 24215592 Free PMC article. Clinical Trial.
-
Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet.Metabolism. 2013 Jan;62(1):137-43. doi: 10.1016/j.metabol.2012.07.002. Epub 2012 Aug 11. Metabolism. 2013. PMID: 22889512 Clinical Trial.
-
Improvements in coronary heart disease risk indicators by alternate-day fasting involve adipose tissue modulations.Obesity (Silver Spring). 2010 Nov;18(11):2152-9. doi: 10.1038/oby.2010.54. Epub 2010 Mar 18. Obesity (Silver Spring). 2010. PMID: 20300080 Clinical Trial.
-
Fasting for weight loss: an effective strategy or latest dieting trend?Int J Obes (Lond). 2015 May;39(5):727-33. doi: 10.1038/ijo.2014.214. Epub 2014 Dec 26. Int J Obes (Lond). 2015. PMID: 25540982 Review.
-
Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings.Transl Res. 2014 Oct;164(4):302-11. doi: 10.1016/j.trsl.2014.05.013. Epub 2014 Jun 12. Transl Res. 2014. PMID: 24993615 Review.
Cited by
-
Health Benefits of Intermittent Fasting.Microb Physiol. 2024;34(1):142-152. doi: 10.1159/000540068. Epub 2024 Jul 2. Microb Physiol. 2024. PMID: 38955141 Review.
-
Stress and human health in diabetes: A report from the 19th Chicago Biomedical Consortium symposium.J Clin Transl Sci. 2023 Nov 20;7(1):e263. doi: 10.1017/cts.2023.646. eCollection 2023. J Clin Transl Sci. 2023. PMID: 38229904 Free PMC article.
-
Protein Supplementation May Dampen Positive Effects of Exercise on Glucose Homeostasis: A Pilot Weight Loss Intervention.Nutrients. 2023 Nov 29;15(23):4947. doi: 10.3390/nu15234947. Nutrients. 2023. PMID: 38068805 Free PMC article.
-
A Bibliometric Analysis of Alternate-Day Fasting from 2000 to 2023.Nutrients. 2023 Aug 25;15(17):3724. doi: 10.3390/nu15173724. Nutrients. 2023. PMID: 37686756 Free PMC article.
-
Effect of Intermittent Fasting on Glycaemic Control in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.touchREV Endocrinol. 2023 May;19(1):25-32. doi: 10.17925/EE.2023.19.1.25. Epub 2023 Jan 17. touchREV Endocrinol. 2023. PMID: 37313231 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous